Soleno Therapeutics Inc (SLNO) — SC 13D/A Filings

SC 13D/A Filings (7)

• Perceptive Advisors Amends Soleno Therapeutics Stake — Nov 19, 2024 Risk: medium
  On November 19, 2024, Perceptive Advisors LLC, through its fund Perceptive Life Sciences Master Fund, Ltd., filed an amendment (No. 8) to its Schedule 13D regar
• Perceptive Advisors Adjusts Soleno Therapeutics Stake — Nov 14, 2024 Risk: medium
  Perceptive Advisors LLC, through its affiliated entities, has amended its Schedule 13D filing regarding Soleno Therapeutics, Inc. as of November 14, 2024. The f
• Carlyle Group Adjusts Stake in Soleno Therapeutics — Oct 21, 2024 Risk: medium
  Carlyle Group Inc. and its affiliates, including Abingworth Bioventures VII LP, have filed an amendment to their Schedule 13D, indicating a change in their bene
• Carlyle Group Files SC 13D/A Amendment for Soleno Therapeutics — Oct 15, 2024 Risk: medium
  On October 15, 2024, Carlyle Group Inc. and its affiliates, including Abingworth Bioventures VII LP, filed an SC 13D/A amendment regarding their holdings in Sol
• Carlyle Group Adjusts Soleno Therapeutics Stake — Oct 10, 2024 Risk: medium
  On October 10, 2024, Carlyle Group Inc. and its affiliates filed an SC 13D/A amendment regarding their holdings in Soleno Therapeutics Inc. The filing indicates
• Carlyle Group Files 13D Amendment for Soleno Therapeutics — Sep 10, 2024 Risk: medium
  Carlyle Group Inc. and its affiliates, including Abingworth Bioventures VII LP, have filed an amendment to their Schedule 13D, reporting a change in beneficial
• Vivo Opportunity Fund Ups Soleno Stake to 10.8% — May 1, 2024 Risk: medium
  Vivo Opportunity Fund Holdings, L.P. filed an amendment (No. 2) to its Schedule 13D on May 1, 2024, regarding its holdings in Soleno Therapeutics, Inc. The fili

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX